Form 4: MaxLinear CFO Litchfield's Equity Award Update

MaxLinear's CFO, Steven G. Litchfield, received a new stock option grant and Restricted Stock Units, replacing an older option.

Summary

• Steven G. Litchfield, MaxLinear's Chief Financial Officer and Chief Corporate Strategy Officer, reported changes in his beneficial ownership.
• An existing stock option for 306,000 shares with an exercise price of $18.4 and an expiration date of August 10, 2025, was cancelled.
• This cancelled option was originally granted on August 10, 2018, and became fully vested on July 2, 2022.
• A new stock option for 306,000 shares with the same exercise price of $18.4 was granted, with a new expiration date of August 10, 2028.
• Additionally, 77,760 Restricted Stock Units (RSUs) were granted on August 4, 2025, with each RSU representing a contingent right to receive one share of MaxLinear, Inc. Common Stock.
• The RSUs will vest in three annual installments, with one-third vesting on May 20, 2026, and one-third annually on each May 20 thereafter, leading to full vesting by May 20, 2028, contingent on continuous service as a Service Provider.

Sentiment

Score: 7

Explanation: The grant of new equity incentives to a key executive like the CFO is generally viewed positively as it aligns management's interests with long-term shareholder value and aids in executive retention, without indicating any immediate negative financial implications.

Positives

• The grant of new stock options and Restricted Stock Units aligns management's interests with long-term shareholder value.
• The new stock option extends the exercise period for 306,000 shares, providing more time for potential value realization.
• The RSU grant provides a long-term incentive for the Chief Financial Officer, promoting retention and performance.

Future Outlook

The filing details future vesting schedules for Restricted Stock Units through May 2028 and the expiration of a new stock option in August 2028, indicating long-term incentive alignment for the Chief Financial Officer.

Industry Context

This filing is specific to an individual's equity compensation and does not provide broader industry context or trends.

Stakeholder Impact

• Shareholders: Potential future dilution from the vesting of RSUs and exercise of stock options, balanced by improved alignment of management's interests with long-term shareholder value.

Next Steps

• Vesting of one-third of the Restricted Stock Units on May 20, 2026.
• Annual vesting of one-third of the Restricted Stock Units on May 20, 2027, and May 20, 2028.
• Potential exercise of the new stock option by its expiration date of August 10, 2028.

Key Dates

Recommendation

This Form 4 details routine equity compensation for a key executive, which aligns management incentives with long-term shareholder value. It does not present new information that would significantly alter the investment thesis for MaxLinear, Inc., thus a 'hold' recommendation is appropriate.

Keywords

MaxLinear, MXL, Steven Litchfield, Stock Option, Restricted Stock Units, RSU, Equity Incentive, CFO, Insider Transaction, SEC Form 4